EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyseOpen Access · CC BY 4.0

Impact of Aspirin Use on Mortality and Cardiac Allograft Vasculopathy After Heart Transplantation: A Systematic Review and Meta‐analysis

Noémie Fournier, Panagiotis Antiochos, Baris Gencer, Anna Nowacka, Tamila Abdurashidova, Patrick Yerly, Philippe Meyer, Valentina Rancati, Zied Ltaief, Olivier Muller, Matthias Kirsch, Roger Hullin und 1 weitere

Clinical Transplantation · 2026-11 · 40 (11)

DOI: 10.1111/ctr.70742 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Clinical Transplantation, online erschienen am 07.11.2026. Verfasst von Noémie Fournier und 12 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiology, Lausanne University Hospital (CHUV), University of Lausanne (UNIL), Lausanne, Switzerland. Hauptthemen laut MEDLINE: Heart Transplantation, Aspirin, Graft Rejection, Postoperative Complications. Die Arbeit nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Cardiac allograft vasculopathy (CAV) remains a major cause of late graft failure and morbidity among heart transplant (HTx) recipients. Aspirin is currently assigned a Class IIb recommendation for CAV prevention, reflecting the limited evidence supporting its clinical benefit. We conducted a systematic review and meta‐analysis to assess the association between aspirin use and clinical outcomes in HTx recipients (PROSPERO ID: CRD420261399873).

Methods

Outcomes of interest included all‐cause mortality and CAV‐related clinical outcomes (graft dysfunction or CAV‐related death). Literature searches were conducted through December 2025 in PubMed and EMBASE. Studies comparing HTx recipients treated with aspirin versus no aspirin were included. Hazard ratios (HRs) and 95% confidence intervals (CIs) were meta‐analyzed across studies.

Results

Five observational studies were included, comprising four adult cohorts and one pediatric cohort. Participants were predominantly male (66.6%), with a mean age of ≈50 years in the four adult studies and 7.4 years in the sole pediatric study. Aspirin use was associated with significantly lower all‐cause mortality (four studies, HR 0.31 [95% CI: 0.15–0.67]). No statistically significant association was observed with CAV‐related clinical outcomes (HR 0.42 [95% CI: 0.10–1.77]).

Conclusions

In HTx recipients, aspirin use was associated with lower all‐cause mortality, while no significant association was observed in the exploratory analysis of CAV‐related clinical outcomes. These findings should be interpreted cautiously given the observational design, substantial heterogeneity, and potential residual and time‐related biases. Prospective studies are needed to determine the efficacy and safety of aspirin after HTx.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Heart TransplantationAspirinGraft RejectionPostoperative ComplicationsVascular DiseasesHumansGraft SurvivalPrognosisRisk FactorsAllograftsSurvival Rate

Stichwörter der Autor:innen

Aspirincardiac allograft vasculopathyheart transplantmeta‐analysis

Substanzen

Aspirin

Autor:innen und Institutionen

  • Division of Cardiology, Lausanne University Hospital (CHUV), University of Lausanne (UNIL), Lausanne, Switzerland.
  • Division of Cardiac Surgery, Lausanne University Hospital (CHUV), University of Lausanne (UNIL), Lausanne, Switzerland.
  • Division of Cardiology, Geneva University Hospitals (HUG), University of Geneva (UNIGE), Geneva, Switzerland.
  • Division of Anesthesiology, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.
  • Department of Adult Intensive Care Medicine, Lausanne University Hospital (CHUV) and University of Lausanne, Lausanne, Switzerland.

Zitieren

APA

Fournier, N., Antiochos, P., Gencer, B., Nowacka, A., Abdurashidova, T., Yerly, P., Meyer, P., Rancati, V., Ltaief, Z., Muller, O., Kirsch, M., Hullin, R., & Lu, H. (2026). Impact of Aspirin Use on Mortality and Cardiac Allograft Vasculopathy After Heart Transplantation: A Systematic Review and Meta‐analysis. Clinical Transplantation, 40(11). https://doi.org/10.1111/ctr.70742

Vancouver

Fournier N, Antiochos P, Gencer B, Nowacka A, Abdurashidova T, Yerly P, et al. Impact of Aspirin Use on Mortality and Cardiac Allograft Vasculopathy After Heart Transplantation: A Systematic Review and Meta‐analysis. Clinical Transplantation. 2026;40(11). doi:10.1111/ctr.70742

BibTeX
@article{Fournier2026,
  author = {Fournier, Noémie and Antiochos, Panagiotis and Gencer, Baris and Nowacka, Anna and Abdurashidova, Tamila and Yerly, Patrick and Meyer, Philippe and Rancati, Valentina and Ltaief, Zied and Muller, Olivier and Kirsch, Matthias and Hullin, Roger and Lu, Henri},
  title = {Impact of Aspirin Use on Mortality and Cardiac Allograft Vasculopathy After Heart Transplantation: A Systematic Review and Meta‐analysis},
  journal = {Clinical Transplantation},
  year = {2026},
  volume = {40},
  number = {11},
  doi = {10.1111/ctr.70742}
}
Kostenlos starten →